6-month Clinical Investigation Assessing the Efficacy of an Antimicrobial Mouthrinse in Reducing Established Plaque and Improving Gum Health

Exclusion Criteria

• •1. Be under orthodontic treatment.
• •2. Presence of partial removable dentures.
• •3. Tumor(s) of the soft or hard tissues of the oral cavity.
• •4. Participants with current moderate or severe periodontitis (periodontitis screening index \[PSI\] \>2 in more than 2 sextants or PSI \>3), and/or purulent exudate, tooth mobility, and/or extensive loss of periodontal attachment or alveolar bone.
• •5. Five or more carious lesions requiring immediate restorative treatment.
• •6. Antibiotic use any time during the one-month period prior to entry into the study.
• •7. Participation in any other clinical study or test panel within the one month prior to entry into the study.
• •8. Dental prophylaxis during the past two weeks prior to baseline examinations.
• •9. History of allergies to oral care/personal care consumer products or their ingredients.
• •10. On any prescription medicines that might interfere with the study outcome based on the examiner/PI opinion.
• •11. An existing medical condition that prohibits eating and/or drinking for periods up to 4 hours.
• •12. History of alcohol and/or drug abuse.
• •13. Self-reported pregnancy and/or lactating subjects.
• •14. Subjects with other oral diseases (including gingival hyperplasia, diseases of the oral mucosa), or any condition that the dental examiner considers exclusionary from the study.
• •15. Smokers or/and users of tobacco products.
• •16. Enrolled in an undergraduate, postgraduate, or academic dentistry program